Huier Ding (惠尔丁)惠尔丁

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

恩曲他滨是一种在国家药监局注册认定的药品。该药品含有s)--氟--(-羟甲基、恩曲他滨、氧硫环--基)胞嘧啶-119875e7等成分。

该药品关联的活性成分包括:s)--氟--(-羟甲基、恩曲他滨Enqu Tabin、氧硫环--基)胞嘧啶Yangliu Huanji Baomi Ding。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:河北医科大学制药厂Chinese legal name: 河北医科大学制药厂。

您可以探索含有相同成分的其他药品:s)--氟--(-羟甲基-2bdb076c成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 惠尔丁) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 恩曲他滨Enqu Tabin, 氧硫环--基)胞嘧啶Yangliu Huanji Baomi Ding.

Manufacturers recorded for this product: 河北医科大学制药厂Chinese legal name: 河北医科大学制药厂.

Explore other medicines containing the same ingredient: s)--氟--(-羟甲基 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 惠尔丁Recorded Chinese name: 惠尔丁
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 0.2g0.2 g

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 河北医科大学制药厂Chinese legal name: 河北医科大学制药厂

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20052301

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20052301

Manufacturer

Chinese legal name: 河北医科大学制药厂 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20052301

生产企业

河北医科大学制药厂(国产)

适应症

1.与其它抗病毒药物合用于成人HIV-1感染的治疗。患者为未经过逆转录酶抑制剂治疗和经过逆转录酶抑制剂治疗病毒已被抑制者。|2.用于慢性乙型肝炎治疗。

用法用量

口服:1次200mg,1日1或2次,空腹或餐后服用。

不良反应

1.临床应用中,接受恩曲他滨和其它抗病毒药物治疗,最常见的不良反应有头痛、腹泻、恶心和皮疹,程度从轻到中等严重。约1%病人因以上原因中止服药。|2.所有不良反应发生频率与对照组相当,但皮肤色素沉着在恩曲他滨组略高,皮肤色素沉着以出现于手掌和或足底明显,一般较轻,且不伴其他症状。

禁忌

对过敏者禁用。

注意事项

本品主要经过肾脏排泄,肾功能不全者宜减量使用。

贮藏

遮光,密封保存。

规格

0.2g

证据Evidence

  • 批准文号: 国药准字H20052301
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.